In a further study of murine diet-induced obesity, the hepatoprotective effect of withaferin A was suggested to be related to the direct activation of liver X receptor a/farnesoid X receptor (LXRα/FXR) [137]. The gene discussed is NR1H4; the disease is obesity disorder.